Ketek's Political Fallout
The negative attention from Capitol Hill over the approval of the antibiotic Ketek is impacting much more than the commercial prospects of a single drug: it's making FDA reviewers think twice about other applications.
The negative attention from Capitol Hill over the approval of the antibiotic Ketek is impacting much more than the commercial prospects of a single drug: it's making FDA reviewers think twice about other applications.